Hough they are typically recognized on the basis of gastrointestinal complaints. > 자유게시판

본문 바로가기

커뮤니티 Korea Sports Science Institute

Hough they are typically recognized on the basis of gastrointestinal complaints.

페이지 정보

작성자Jeanna 작성일 23-08-08 조회수 41회

본문

Hough they are typically recognized on the basis of gastrointestinal complaints. The case of our patient demonstrates a rare initial clinical presentation of metastatic carcinoid tumor with right shoulder pain after the patient had a fall. The diagnosis was challenging. The patient was treatedTun and Oza Journal of Medical Case Reports 2014, 8:142 http://www.jmedicalcasereports.com/content/8/1/Page 7 of13. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB: One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008, 26:3063?072. 14. Fj lskog ML, Granberg DP, Welin SL, Eriksson C, Oberg KE, Janson ET, Eriksson BK: Treatment with cisplatin and etoposide in patients with neuroendocrine tumors. Cancer 2001, 92:1101?107. 15. Mitry E, Baudin E, Ducreux M, Sabourin JC, Rufi?P, Aparicio T, Lasser P, Elias D, Duvillard P, Schlumberger M, Rougier P: Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer 1999, 81:1351?355.doi:10.1186/1752-1947-8-142 Cite this article as: Tun and Oza: Atypical presentation of carcinoid tumor with unresolved right shoulder pain: a case report. Journal of Medical Case Reports 2014 8:142.Submit your Capmatinib next manuscript to BioMed Central and take full advantage of:?Convenient online submission ?Thorough peer review ?No space constraints or color figure charges ?Immediate publication on acceptance ?Inclusion in PubMed, CAS, Scopus and Google Scholar ?Research which is freely available for redistributionSubmit your manuscript at www.biomedcentral.com/submit
Ferlazzo et al. BMC Neurology 2014, 14:148 http://www.biomedcentral.com/1471-2377/14/CASE REPORTOpen AccessPositivity to p-ANCA in patients with status epilepticusEdoardo Ferlazzo1,2, Antonio Gambardella1,3*, Marina Bellavia1,2, Sara Gasparini1,2, Laura Mumoli1,3, Angelo Labate1,3, Vittoria Cianci2, Concetta Russo2 and Umberto Aguglia1,AbstractBackground: Status epilepticus (SE) may occur in the setting of several internal or neurologic diseases. Anti-neutrophilic cytoplasmic antibodies (ANCA) are a group of Ig that may be observed in patients with different autoimmune disorders but are particularly associated with systemic vasculitis named ANCA-associated-vasculities (AAV). We herein report 3 patients with SE and positivity to p-ANCA. Case presentation: One patient had a catastrophic evolution and died 5 months after disease onset. The other two patients had a good outcome and remained seizure-free at 30 months and 5 years PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/16989806 of follow-up respectively. Conclusion: This report highlights the importance of considering ANCA dosage in patients with SE of unclear origin. Keywords: Vasculitis, Seizures, p-ANCA, Epilepsy, Status epilepticus, DeathBackground Status epilepticus (SE) may occur in the setting of several neurologic or internal diseases. Anti-neutrophilic cytoplasmic antibodies (ANCA) are a group of Ig that may be observed in patients with different autoimmune disorders but are particularly associated with systemic vasculitis. ANCA-associated vasculitis (AAV) are rare systemic autoimmune diseases affecting small to medium sized blood vessels [1]. AAV include granulomatosis with polyangiitis (formerly Wegener's granulomatosis), microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome). These conditions may rapidly lead to.

go top